Opiant Pharmaceuticals, Inc. (OPNT) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Grant
0250K500K750K1M1M2M2M2MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
050M100M150M200M250M300M350M400MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
02B5B8B10B12B15B18B20BQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

EBITDA

EBITDA
-20M-17M-14M-11M-8M-4M-1M2M5MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

EPS

EPSEPS Diluted
000111222Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Revenue Variation (%)

Revenue Variation
-1001K2K3K4K6K7K8K9KQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
02K5K8K10K12K15K18K20KQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Revenue YoY Variation (%)

Revenue YoY Variation
-901714326949551K1K2K2KQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
02505007501K1K2K2K2KQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Price-to-Earning Ratio

P/E Ratio
-3513212836445260Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
01M2M3M4M6M7M8M9MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
0510152025303540Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
012234456Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0625K1M2M2M3M4M4M5MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Free Cash Flow

Cash At End Of Period
08M15M22M30M38M45M52M60MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
0375K750K1M2M2M2M3M3MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022
🏦 Balance Sheet
📈 Key Metrics